Karen Lauxmann, Contract Manufacturing Sales, United Kingdom

Intelligent collaboration with Pfizer CentreOne

We’re experts in the production of therapeutic proteins using expression in recombinant organisms including: 

  • Vaccines including native and conjugated polysaccharides, lipoproteins and soluble proteins in monovalent or multivalent presentations. 
  • Proteins including monoclonal antibodies (mAbs), bi-specific clonal antibodies (BsAbs) fusion proteins and native proteins, with or without conjugation to payloads or half-life extenders (e.g. PEG).

We deliver reliable lyophilization as well as comprehensive vial and syringe drug product capabilities. 


We develop and manufacture your products using Pfizer’s Global Quality Systems. 

You gain access to comprehensive quality control services compliant with the European (Ph.Eur.), United States (USP) and Japanese (JP) Pharmacopeias and a regulatory team with experience of working collaboratively with authorities across the globe. 

Guiding your molecule to market

Collaborating with us gives you access to product technology transfer expertise. We’ll help guide your large molecule biologics from development to commercial-scale manufacture. 

Our bench and pilot-scale studies can enhance process development, process optimization and tech-transfer capabilities, reducing downstream manufacturing risk and ensuring long-term clinical and commercial supply. 

Capabilities at a glance

Large Molecule Biologics

  • Cell culture medium development and optimization
  • Upstream and downstream process development and optimization
  • Full development of analytical methods 
  • Scale-up from lab to pilot to commercial
  • Specification development
  • Regulatory support - pre and post-launch
  • Clinical manufacturing Ph I - III
  • Biosafety levels 1-2
  • Vaccines & monoclonal antibodies